Disorder of Consciousness Related Pattern Could Distinguish Minimally Conscious State from Unresponsive Wakefulness Syndrome: A F-18-FDG-PET Study

Zhijie He,Rongrong Lu,Jingjie Ge,Yihui Guan,Ying Chen,Gang Liu,Hongyu Xie,Yulong Bai,Yi Wu,Junfa Wu,Jie Jia
DOI: https://doi.org/10.1016/j.brainresbull.2024.111023
IF: 3.715
2024-01-01
Brain Research Bulletin
Abstract:BACKGROUND:Accurate evaluation of level of disorder of consciousness (DOC) is clinically challenging. OBJECTIVE:This study aimed to establish a distinctive DOC-related pattern (DOCRP) for assessing disease severity and distinguishing unresponsive wakefulness syndrome (UWS) from minimally conscious state (MCS). METHODS:Fifteen patients with DOC and eighteen health subjects with F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) were enrolled in this study. All patients were assessed by Coma Recovery Scale-Revised (CRS-R) and all individuals were randomly divided into two cohorts (Cohort A and B). DOCRP was identified in Cohort A and subsequently validated in Cohort B and A+B. We also assessed the discriminatory power of DOCRP between MCS and UWS. RESULTS:The DOCRP was characterized bilaterally by relatively decreased metabolism in the medial and lateral frontal lobes, parieto-temporal lobes, cingulate gyrus and caudate, associated with relatively increased metabolism in the cerebellum and brainstem. DOCRP expression exhibited high accuracy in differentiating DOC patients from controls (P<0.0001, AUC=1.000), and furthermore could effectively distinguish MCS from UWS (P=0.037, AUC=0.821, sensitivity: 85.7 %, specificity: 75.0 %). Particularly in the subgroup of DOC patients survived global hypoxic-ischemic brain injury, DOCRP expression exhibited even better discriminatory power between MCS and UWS (P=0.046, AUC=1.000). CONCLUSIONS:DOCRP might serve as an objective biomarker in distinguishing between UWS and MCS, especially in patients survived global hypoxic-ischemic brain injury. TRIAL REGISTRATION NUMBER:ChiCTR2300073717 (Chinese clinical trial registry site, http://www.chictr.org).
What problem does this paper attempt to address?